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ABSTRACT
The mangrove plant is known to produce secondary metabolite compounds, mainly isoprenoids. Polyisoprenoids (dolichol 
and polyprenol) are known to have antimicrobial, anticancer and antiviral activity. Therefore, this study aimed to 
determine the cytotoxic effects of polyisoprenoids from Rhizophora mucronata and Ceriops tagal leaves by evaluating 
the induction of apoptosis and cell cycle arrest and the inhibition of the expression of Bcl-2 and cyclin D1 in WiDr colon 
cancer cells. Cell death was determined based on IC50 values in MTT assays. The induction of apoptosis and alterations 
in the cell cycle were observed by flow cytometry. The expression of Bcl-2 and cyclin D1 proteins, which play a role in 
apoptosis and cell cycle regulation, was observed by immunocytochemistry. The results showed that polyisoprenoids 
from R. mucronata and C. tagal leaves exhibited toxicity against the WiDr cell line, with IC50 values of 278 ± 5.77 and 
276 ± 9.54 µg/mL, respectively. Polyisoprenoids from R. mucronata and C. tagal leaves significantly induced apoptosis 
and caused cell cycle arrest in G0/G1 phase, while also decreasing the expression of Bcl-2 and cyclin D1. Our results 
confirmed that polyisoprenoids from R. mucronata and C. tagal leaves have the potential to be developed as anticancer 
agents for colon cancer.
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ABSTRAK
Tumbuhan bakau diketahui menghasilkan sebatian metabolit sekunder, terutamanya isoprenoid. Poliisoprenoid (dolichol 
dan poliprenol) diketahui mempunyai aktiviti  antimikrob, antikanser dan antivirus. Oleh itu, kajian ini bertujuan untuk 
menentukan kesan sitotoksik poliisoprenoid daripada daun Rhizophora mucronata dan Ceriops tagal dengan menilai 
induksi apoptosis tangkapan kitaran sel serta kesan ekpresi Bcl-2 dan siklin D1 dalam titisan sel kanser kolon WiDr. 
Kematian sel ditentukan berdasarkan nilai IC50 dalam asai MTT. Induksi apoptosis dan perubahan dalam kitaran sel 
diperhatikan dengan aliran sitometri. Ekpresi Bcl-2 dan protein siklin D1 yang memainkan peranan dalam apoptosis dan 
kawal-selia kitaran sel diperhatikan melalui imunositokimia. Keputusan menunjukkan bahawa  poliisoprenoid daripada 
daun R. mucronata dan C. tagal mengeluarkan ketoksikan terhadap titisan sel WiDr, masing-masing dengan nilai IC50 
278 ± 5.77 dan 276 ± 9.54 µg/mL.  Poliisoprenoid daripada daun R. mucronata dan C. tagal dengan ketara mengaruh 
apoptosis dan menyebabkan tangkapan kitaran sel dalam fasa G0/G1, selain menurunkan ekspresi Bcl-2 dan siklin D1. 
Keputusan kami mengesahkan bahawa poliisoprenoid daripada daun R. mucronata dan C. tagal mempunyai potensi 
untuk dibangunkan sebagai agen anti-kanser untuk kanser kolon. 
Kata kunci: Apoptosis; Ceriops tagal; dolichol; Rhizophora mucronata; sitotoksik 
INTRODUCTION
Colorectal cancer, also referred to as colon cancer, is a 
malignant disease that occurs in the colon, rectum and 
appendix. Colon cancer is a deadly disease around the 
world that affects both men and women. Colon cancer is 
a leading cause of cancer deaths and ranking third for both 
sexes (Siegel et al. 2017). The incidence of colon cancer 
is about one million cases per year, with approximately 
522,000 deaths per year (Ferlay et al. 2015). The 
pathophysiology of colon cancer involves several causes, 
such as changes in histopathologically normal colonic cells 
through molecular events. Another cause is the formation 
of adenomatous polyps that develop into colon cancer due 
to the process of carcinogenesis. Most colon cancers are 
adenocarcinomas (Corley et al. 2014). Chemotherapy is 
one of the treatments used for cancer, but it has unpleasant 
side effects, such as various skin reactions, hypersensitivity 
reactions, and peripheral neuropathy (Iwamoto 2013). Most 
of the currently used anticancer drugs, such as doxorubicin, 
have undesirable side effects, such as cardiotoxicity and 
tumour drug resistance (Leonard et al. 2009).
 Alternative cancer treatments can be developed by 
utilizing naturally occurring compounds. Therefore, there 
is a need for research on alternative treatments for colon 
cancer to identify effective and efficient treatments based 
on natural ingredients. Various efforts to find alternative 
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medicines are underway to identify drugs that have high 
efficacy but little side effects for patients. One source that 
can be exploited for anticancer therapies is herbal medicine 
(Reddy et al. 2003). One group of plants that can be used 
for cancer treatment is the mangroves (Bandaranayake 
1998). Mangroves are well known for producing 
secondary metabolite compounds, mainly isoprenoid. 
Polyisoprenoids are not toxic and are known to show some 
pharmacological activity as anticancer (Kuznecovs et al. 
2007), antidyslipidemic (Singh et al. 2007), anti-influenza 
and antiviral agents (Safatov et al. 2005). In previous 
studies, polyisoprenoids (> C30) have been isolated and 
characterized from mangrove forests in Iriomote Island, 
Japan, and North Sumatra, Indonesia (Basyuni et al. 2018, 
2017, 2016).
 Rhizophora mucronata and Ceriops tagal are two of 
the most widespread plants in Indonesia. R. mucronata has 
various benefits as an antiviral (Premanathan et al. 1996) 
and has antibacterial, cytotoxic, analgesic and diuretic 
activities (Howlader et al. 2013). C. tagal also has various 
benefits such as antiviral (Sudheer et al. 2011), antitumour 
(He et al. 2007), antimicrobial (Dhas et al. 2013) and 
antihyperglycaemic activity (Tiwari et al. 2008). These 
studies suggest that polyisoprenoids from R. mucronata 
and C. tagal leaves can act as chemopreventive agents, 
and they are also some of the most important mangrove 
species to be investigated. 
 This research aimed to examine the cytotoxic activity 
of polyisoprenoids from R. mucronata and C. tagal leaves 
against WiDr colon cancer cell lines. These compounds 
inhibited the cell cycle and induced apoptosis of WiDr cells 
through the inhibition of Bcl-2 and cyclin D1 proteins. The 
results of this study are expected to be the basis for the 
development of polyisoprenoids from R. mucronata and 
C. tagal leaves as anticancer agents for colon cancer. 
MATERIALS AND METHODS
PLANT MATERIALS AND ISOLATION OF POLYISOPRENOIDS
The leaves of R. mucronata and C. tagal were obtained 
from Lubuk Kertang, Langkat, North Sumatera province, 
Indonesia. The isolation of polyisoprenoids was performed 
as previously described (Arifiyanto et al. 2017; Basyuni et 
al. 2017, 2016). The leaves of R. mucronata and C. tagal 
were dried at room temperature for a week and ground 
into powder. The dried leaves powder (500 g) extracted 
with a mixture of chloroform methanol with a ratio 2:1 (2 
chlorofrom: 1 methanol, v/v) solvent for 48 h. The lipid 
extract from the leaves was saponified at 65ºC for 24 h in 
86% ethanol containing 2 M KOH. The nonsaponifiable 
lipids were extracted with hexane, and the organic solvent 
was evaporated and re-dissolved in hexane.
CELL LINE AND CULTURE CONDITIONS
WiDr cells (colon adenocarcinoma) were kindly provided 
by the Parasitology Laboratory, Faculty of Medicine, 
Gadjah Mada University, Yogyakarta, Indonesia. The cells 
were cultured in RPMI 1640 medium (Gibco, Carlsbad, CA, 
USA) supplemented with 10% (v/v) foetal bovine serum 
(FBS) (Sigma-Aldrich, St. Louis, MO, USA), 2% penicillin-
streptomycin (Sigma-Aldrich, St. Louis, MO, USA), and 
0.5% fungizone (Sigma-Aldrich, St. Louis, MO, USA), in 
a 37°C incubator with 5% CO2 (Heraeus).
PREPARATION OF STOCK SOLUTION
Respectively 50 mg polyisoprenoids from R. mucronata 
and 50 mg polyisoprenoids from C. tagal was dissolved 
in 10 mL of RPMI 1640 medium with the help of 1 mL of 
DMSO (Sigma-Aldrich, St. Louis, MO, USA) to obtain a 
concentration of 5000 μg/mL. With a multilevel dilution 
scheme, a range of concentrations was obtained (15.625, 
31.25, 62.50, 125, 250 and 500 μg/mL). 
CYTOTOXICITY TEST
WiDr cells were grown in 96-well microplates to obtain a 
density of 5 × 103 cells/well and incubated at 5% CO2 and 
37°C for 24 h to achieve confluent growth. Afterwards, 
the diluted test samples with the co-solvent DMSO were 
added to the medium and the cells were incubated at 
37ºC in 5% CO2 for 24 h. At the end of the incubation, 
the medium containing the extracts was discarded and 
the cells were washed with PBS. Next, 100 μL of RPMI 
culture medium and 10 μL of MTT (Sigma-Aldrich, St. 
Louis, MO, USA) at a concentration of 5 mg/mL were 
added to each well. The cells were incubated for 4-6 h 
in 5% CO2 at 37ºC. The MTT reaction was stopped with 
10% sodium dodecyl sulphate (Sigma-Aldrich, St. Louis, 
MO, USA) in 0.01 N HCl (Merck, Darmstadt, Germany) 
and the plate was then wrapped and left for overnight at 
room temperature. The absorption was read on an ELISA 
reader (Benchmark Bio-Rad, Hercules, CA, USA) at 595 
nm wavelength. The data obtained in the form of the 
absorbance of each well were converted into the percent 
cell viability. Then, to recover linearity between the 
log concentration and cell viability, the IC50 value was 
calculated using probit analysis in SPSS.
MEASUREMENT OF APOPTOTIC CELLS AND CELL CYCLE 
DISTRIBUTION USING FLOW CYTOMETRY
WiDr cells were grown on 6-well plates with each well 
containing 1 × 106 cells in a 5% CO2 incubator at 37°C for 
24 h. After incubation for 24 h, extracts at concentrations 
of 1 IC50, ½ IC50, 1/5 IC50 and 1/10 IC50 were added to 
each well and the plates were incubated under the same 
conditions as previously described. Then, the medium was 
removed from each well and placed in 15 mL conical tubes 
and the cells were washed with PBS. Trypsin (250 μL) was 
added to each well and the cells were incubated for 3 min 
in the CO2 incubator; then, the liquid was placed in an 
Eppendorf tube and centrifuged at 2500 rpm for 5 min. 
The cells in each Eppendorf tube were washed with cold 
PBS by centrifugation at 1500 rpm. For apoptotic testing, 
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annexin V (BioLegend, San Diego, CA, USA) and propidium 
iodide (BioLegend, San Diego, CA, USA) were added, 
while for cell cycle testing, added only propidium iodide 
and incubated the cells for 10 min in the dark. The flow 
cytometry analysis was performed by using FACSVerse (BD 
Biosciences) after less than 1 h. The results were analysed 
using CellQuest Pro software.
IMMUNOCYTOCHEMISTRY ASSAY
WiDr cells were grown in a 24 well-plate with a coverslip 
whereby in each well 5×104 cells/well were added and 
then grown in a 5% CO2 incubator at 37οC for 24 h. Then, 
added an extract at a concentration of 1 IC50 and incubated 
the cells further. After 24 h, the cells were washed with 
PBS and cold methanol was added. Then, added 3% H2O2 
in PBS, pH7.4, to each of the wells, followed by blocking 
buffer and incubated the cells for 1 h. Then, each well 
was incubated for at least 1 h with the relevant primary 
antibody (human anti-Bcl-2/anti-cyclin D1) (Santa Cruz 
Biotechnology, Dallas, TX, USA) at a 1:100 dilution in 
PBS with 1% FBS. Secondary antibody a biotinylated 
anti-rabbit IgG (Vector Laboratories, Inc., Burlingame, 
CA, USA) was then added to each well and the plates 
were incubated at room temperature for 10 min and then 
washed with PBS. A 3,3ʹ-diaminobenzidine solution, as 
the chromogen, was added to the cells for 5 min. Next, 
washed the plates with distilled water, stained the cells 
with haematoxylin and visualized the colour reaction. 
Bcl-2 and cyclin D1 protein expression was observed 
using an inverted light microscope (Olympus, Tokyo, 
Japan) and documented. 
DATA ANALYSIS
Data were presented as the mean ± SD of at least three 
independent experiments. Data were analysed by one-way 
analysis of variance (ANOVA) followed by Duncan’s test 
for comparisons of all treatments. All statistical analyses 
were performed using SPSS version 23. Differences were 
considered significant at p<0.05.
RESULTS
EFFECT OF POLYISOPRENOIDS FROM R. MUCRONATA AND      
C. TAGAL LEAVES ON CELL VIABILITY
A cytotoxic test was performed to determine the toxicity 
potential of polyisoprenoids from R. mucronata and C. 
tagal leaves expressed as the IC50. Treatment of WiDr 
cells with polyisoprenoids from R. mucronata and C. tagal 
leaves extract over a concentration range of 15.625, 31.25, 
62.525, 125, 250 and 500 μg/mL showed the IC50 values 
of polyisoprenoids from R. mucronata and C. tagal leaves 
to be 278±5.77 μg/mL and 276±9.54 μg/mL, respectively. 
Polyisoprenoids from R. mucronata and C. tagal leaves 
showed a dose-dependent inhibitory effect on WiDr cells 
after 24 h of treatment (Figure 1).
EFFECTS OF POLYISOPRENOIDS FROM MANGROVE LEAVES 
ON APOPTOSIS AND CELL CYCLE ARREST OF WIDR CELLS
Staining with annexin V and propidium iodide to 
detect apoptosis using an Annexin V-FITC Apoptotic Kit 
showed increased apoptosis in WiDr cells exposed to 
polyisoprenoids from R. mucronata and C. tagal leaves for 
24 h compared with control cells (Figure 2). The percentage 
of dead cells and the rate of apoptosis increased in a dose-
dependent fashion. 
 To investigate the cytotoxic mechanisms of 
polyisoprenoids from R. mucronata and C. tagal leaves, 
the cell cycle distribution of WiDr cells treated with various 
concentrations of polyisoprenoids from R. mucronata and 
C. tagal leaves was examined by a FACScan flow cytometer. 
Our results showed that the number of WiDr cells arrested 
in G0/G1 increased after exposure to polyisoprenoids from 
R. mucronata and C. tagal leaves compared with that of 
control cells (Table 1).
INHIBITION OF BCL-2 AND CYCLIN                                                
D1 PROTEIN EXPRESSION
As shown in Figure 3, immunocytochemistry analysis 
of Bcl-2 and cyclin D1 protein expression in WiDr cells 
(5 × 104 cells/mL) treated with polyisoprenoids from R. 
mucronata and C. tagal leaves resulted in down-regulation 
of Bcl-2 and cyclin D1 compared with control cells.
 Based on the immunocytochemical test results, we 
confirmed the semi-quantitative analysis. Polyisoprenoids 
from R. mucronata and C. tagal leaves significantly 
suppressed Bcl-2 and cyclin D1 expression in WiDr 
cells (p<0.05) (Table 2). These data suggested that 
polyisoprenoids from R. mucronata and C. tagal leaves 
inhibited the expression of Bcl-2 and cyclin D1 in WiDr 
cells.
DISCUSSION
The cytotoxicity test in this study was conducted to 
determine the potential toxicity of polyisoprenoids from 
R. mucronata and C. tagal leaves against the colon cancer 
WiDr cell line. The cytotoxic activity of polyisoprenoids 
from R. mucronata and C. tagal leaves was determined 
by MTT method by looking at cell viability which one of 
anticancer activity test based on cell ability to survive 
exposure to toxic compounds (Ulukaya et al. 2008). 
The cytotoxic nature is a major step in the discovery of 
new anticancer drugs derived from nature (Harvey et al. 
2015). In this study as shown in Figure 1, administration 
of polyisoprenoids from R. mucronata and C. tagal leaves 
can cause death of colon cancer cell WiDr at highest dose 
is 278 ± 5.77 μg/mL and 276 μg/mL ± 9.54, respectively. 
This suggests that the higher concentration of the test 
samples given the smaller percentage of cancer cell life 
and the greater the toxicity.
 Polyisoprenoids contained in the leaves of R. 
mucronata and C. Tagal were shown cell cycle arrest 
and induced apoptosis as shown through flow cytometry. 
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PRM= Polyisoprenoids from R. mucronata; PCT= Polyisoprenoids from C. tagal. Each value represents the mean of three independent experiments
FIGURE 2. Apoptosis assay using flow cytometry after annexin V-FITC and propidium iodide (PI) staining (a) Untreated cells, 
(b) PRM at 27.8 μg/mL, (c) PRM at 55.6 μg/mL, (d) PRM at 139 μg/mL, (e) PRM at 278 μg/mL, (f) Untreated cells, 
(g) PCT 27.6 μg/mL, (h) PCT 55.2 μg/mL, (1) PCT 138 μg/mL, (j) PCT 276 μg/mL
(b)
(a)
FIGURE 1. Percentage of growth inhibition of WiDr cells after treatment with polyisoprenoids from R. mucronata and 
C. tagal leaves (a) Polyisoprenoids from R. mucronata leaves (b) Polyisoprenoids from C. tagal leaves
The inhibition of cell cycle is an important strategy for 
controlling the growth of cancer cells (Qui et al. 2011). 
From the results of this study, cell accumulation at the 
G0/G1 phase was observed in WiDr cells treated with 
polyisoprenoids from R. mucronata and C. tagal leaves 
(Table 1). The inhibition of cell cycle at phase G0/G1 
may be contributed by the presence of polyisoprenoids in 
leaves of R. mucronata and C. tagal (Elson et al. 1999). Mo 
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and elson (2004) demonstrated isoprenoid synergistically 
inhibits human DU145 and LNCaP prostate carcinoma and 
murine B16 melanoma cells. This isoprenoid induces G1 
arrest and initiates apoptosis and differentiation, an effect 
associated with modulating the cellular signal pathway 
by either modulating gene expression, suppressing 
translational signal processing and post-translational 
growth factor receptors, or altering dlacylglycerol signals 
(Mo & Elson 2004). Isoprenoid also induces G1 growth 
capture in GBM cells (A172, U87 and U251) and breast 
cancer cells (MDA-MB-231, 432, 435) (Jiang et al. 2014). 
Polyisoprenoids from R. mucronata and C. tagal proven 
caused cancer cells die. Polyisoprenoids from R. mucronata 
and C. tagal leaves has been reported to contain 100% 
dolichol (C75-C90) but no polyprenol detected (Basyuni 
et al. 2017). Treatment with dolichol significantly 
interferes with the function of Ras and Rho GTPase family, 
with inhibition of cyclin-dependent kinases (CDKs) and 
activation of CDK inhibitors (Jakobisiak & Golab 2003). 
Dolichol is one of the derivatives of mevalonic acid. 
Mevalonic acid is a precursor in the biosynthesis of 
isoprenoid compounds, enabling proper functional and 
cellular refinement of many proteins such as Ras and Rho 
(Wiemer et al. 2009). In several previous studies dolichol 
significantly delayed growth arrest in human breast cancer 
cells Hs578T and MDA231 (Larsson 1994).
 In this study, treatment of cancer cells (the colon 
cancer cell line WiDr) with polyisoprenoids from R. 
mucronata and C. tagal leaves suppressed the expression of 
Bcl-2 and cyclin D1 protein (Table 2; Figure 2) and induced 
apoptosis (Figure 1). Previous studies of isoprenoid have 
been shown to induce apoptosis (Holstein & Hohl 2004; 
TABLE 1. Cell cycle distribution of WiDr cells after treatment with polyisoprenoids from R. mucronata and C. tagal leaves
Treatment Concentration 
μg/mL
% Cells in each phase
G0/G1 S G2/M
Control 0 64.53 18.20 17.00


































Data are presented as the mean ± SD, n=3
(a) (b)
(c) (d)
Brown colour: Bcl-2 and cyclin D1 expression
FIGURE 3. The observation of Bcl-2 and cyclin D1 expression in cells by immunocytochemistry under 
a light microscope at 400× magnification (a) Untreated cells (Bcl-2 negative control), (b) cells treated 
with 278 μg/mL polyisoprenoids from R. mucronata leaves, (c) untreated cells (cyclin D1 negative 
control), and (d) cells treated with 276 μg/mL polyisoprenoids from C. tagal leaves 
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Sakagami et al. 2000). One such group of phytochemicals 
the terpenoids is found in nature. Terpenoids, also referred 
to as terpenes or isoprenoid, are phytochemicals present 
in R. mucronata and C. tagal leaves including lupanes, 
dammaranes, oleans and dolabranes (Nebula et al. 2013; 
Zhang et al. 2005). Some of these compounds are known 
to provide an overview of the antitumor potential of these 
agents against various cancers (Bishayee et al. 2011; 
Laszczyk & Pentacyclic 2009; Liby et al. 2007; Petronelli 
2009; Setzer & Setzer 2003). One of the derivates lupanes 
is found in the leaves of R. mucronata and C. tagal that 
causing simultaneous apoptotic induction, decreased 
Bcl-2 and cyclin D1 and increased Bax gene expression 
(Bishayee et al. 2011). The transition of cell cycle from 
one phase to another depends on the complex regulation 
of cyclin-dependent kinases (CDKs), the active agent that 
phosphorylates substrate involved in the cell cycle. The 
G1 phase to S phase of the cell cycle is controlled by a 
number of cyclin members, including cyclin D1 (Otto & 
Sicinski 2017). Previous research has shown that excessive 
expression of cyclone D is seen in many human cancers 
(Vermuelen et al. 2003). Inhibition of cyclin D1 expression 
is considered an excellent target in searching for possible 
chemotherapy and chemo preventative agents.
CONCLUSION
In summary, the results obtained from this study showed 
that polyisoprenoids from R. mucronata and C. tagal 
leaves have cytotoxic effects via apoptosis and arresting 
the human colon cancer cell line WiDr at the G0/G1 phase. 
Polyisoprenoids from R. mucronata and C. tagal leaves 
appear to be apoptosis-inducing agents and to cause arrest 
in G0/G1 phase by down-regulating the protein expression 
of Bcl-2 and cyclin D1, which both play an essential role 
in apoptosis and cell cycle arrest. These present data can 
facilitate the development of new treatments for colon 
cancer and other malignancies that are difficult to treat 
and are life-threatening.
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